PERSANI, LUCA
PERSANI, LUCA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Response to the Letter to the Editor: "Hypertensive Hypercortisolism: What Does 1.14 μg/dL Really Mean?"
2026 A. Musolino, V. Favero, G. Bilo, A. Croce, M. Pengo, G. Parati, L. Persani, A. Scillitani, I. Chiodini, V. Morelli
The diagnostic puzzle of thyroid paraganglioma: when the usual suspects fail—a case report
2026 F. Brucchi, A. Satta, A. Leone, C. Colombo, L. Persani, G. Dionigi, G. Gazzano
Beyond teaching and research: the hidden economic value of university-affiliated physicians in Italian public hospitals
2026 F. Brucchi, L. Persani, G. Parati, L. Boni, G. Carrafiello, P. Miccoli, R. Dionigi, G. Dionigi
High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids
2026 S. Rodolfi, G.M. Vannucchi, M. Perrino, C. Colombo, D. Covelli, L. Persani, L. Fugazzola, I. Campi
Patient-Derived in Vitro Models Reveal Insights into Medullary Thyroid Cancer Microenvironment and Resistance to Tyrosine Kinase Inhibitors
2026 E. Grassi, V. Ghiandai, G. Gaudenzi, E. Massardi, V. Cirello, E. Carbone, D. Gentilini, S. Uraghi, G. Gazzano, G. Dionigi, C. Colombo, G. Vitale, L. Fugazzola, L. Persani
Diet plays a supportive role in managing thyroid disorders – but a critical one!
2026 L. Persani, L. H Duntas
Validation of the 2025 ATA risk stratification system in a cohort of patients with papillary thyroid carcinoma
2026 C. Moneta, M. Trevisan, C. Colombo, A. De Luca, M. Lugaresi, G. Reali, G. Gazzano, L. Persani, L. Fugazzola, S. De Leo
Development of a sensitive plasma lenvatinib quantification method and validation in thyroid cancer patients
2026 C. Colombo, R. Ottria, M. Trevisan, E. Carbone, C. Moneta, M. Lugaresi, S. Casati, S. Vanerio, D. Ceruti, M. Succi, V. Cirello, S. De Leo, L. Persani, P. Ciuffreda, L. Fugazzola
Main outcomes of the HEBE trial: improving cardiorespiratory fitness and body composition through a tailored feasible lifestyle program
2026 D. Lucini, F. Rota, G. Marano, G. Oggionni, E. Luconi, S. Iodice, F. Bianchi, C. Mando’, G. Bernardelli, M. Malacarne, S. Castaldi, P. Boracchi, V. Bollati, M. Clerici, E. Biganzoli, F. Ambrogi, B. Arosio, M. Aureli, G. Baron, M. Baruscotti, C. Battaglia, C. Bellocchi, S. Bellosta, C. Bernardelli, M. Bonomi, F. Bravi, P. Brocca, A. Brucato, A. Bucchi, M. Camera, N. Caporale, G. Cappelletti, A. Caretti, L. Casati, S. Castaldi, S. Castiglioni, M.G. Cattaneo, R. Cazzola, S. Centanni, I. Cetin, R. Chiaramonte, I. Chiodini, E. Chiricozzi, P. Ciana, V. Citro, M.S. Clerici, C.B. Cogliati, S.L. Corbetta, F. D’Addio, A. D’Amato, C.M.L. Dallanoce, M.V. Dei Cas, E. Del Favero, A. Delle Fave, G. Dias Rodrigues, E. Dozio, V. Edefonti, C. Fenizia, L. Ferrari, M. Ferraroni, P. Fiorina, D.M.M. Fornasari, M. Fumagalli, N. Gagliano, E.R. Galliera, J.A.E. Geginat, D. Giannandrea, F. Ingegnoli, C.A.M. La Porta, C.V.B. La Vecchia, D. Lecca, E.A. Lesma, P. Limonta, C. Loretelli, D. Lucini, V. Martini, C. Matera, N. Montano, L. Pantoni, N. Papini, R.C. Paroni, C. Perego, L. Persani, A. Pistocchi, N. Platonova, G. Podda, P.T. Rise', P.V. Riva, A.M. Rizzo, V.M. Rondelli, M. Rossi, F. Rota, M. Ruscica, V.M. Savasi, M. Scavone, L. Sfondrini, L. Sironi, M. Sommariva, G. Testa, E. Tobaldini, C.A. Tringali, E. Verduci, M. Vicenzi, C.A. Vigano', G. Vistoli, G. Vitale
Progression of acromegalic joint and psychological complications according to sex, treatments, and disease control
2026 B. Cangiano, M. Corbetta, C. Premoli, D. Soranna, G. Vitale, S. Grottoli, V. Cambria, P. Maffei, F. Dassie, S. Cannavò, M. Ragonese, A. Zambon, M. Bonomi, L. Persani, L.M. Fatti, M. Scacchi
The CHK1 inhibitor Prexasertib is effective against in vitro models of aggressive thyroid carcinomas with defective p53 function
2026 A. Manzo, E.S. Grassi, M.O. Borghi, C. Colombo, L. Persani, V. Cirello
ERAS thyroidectomy within the Italian DRG-based public health system: surgical efficiency is penalized
2026 F. Brucchi, C. Colombo, P.P.C.A. Bianchi, G. Mercante, D. Barbieri, D. Lombardi, G. Spriano, M. Bussi, L. Giordano, L. Boni, P. Danelli, L. Persani, G. Materazzi, P. Miccoli, R. Dionigi, G. Dionigi
Adherence to growth hormone treatment in the transition age: A prospective observational multicenter study
2026 C. Guzzetti, P. Van Dommelen, L. Casula, M. Cappa, M. Caruso, A. Maria Colao, M. Doknic, N. Di Iorgi, L. Persani, G. Pozzobon, M. Salerno, S. Loche
How genetics changed or will change the therapy in thyroid nodules with indeterminate cytology?
2026 M. Muzza, C. Colombo, L. Fugazzola, L. Persani
Rebound Thymic Hyperplasia after Recovery from Ectopic Cushing Syndrome: A Case Report and Literature Review
2026 A. Musolino, E. Cairoli, A. Palleschi, P. Toja, M. Chiodaroli, S. Corbetta, L. Persani, V. Morelli
Impatto della down-regolazione di wfs1b sui neuroni GnRH3 nel modello in vivo zebrafish
2025 I. Gentile, F. Marelli, S. Casafina, F. Hrvat, L. Persani, V. Vezzoli, M. Bonomi
Impatto della down-regolazione di wfs1b sui neuroni GnRH3 nel modello in vivo zebrafish
2025 I. Gentile, F. Marelli, S. Casafina, F. Hrvat, L. Persani, V. Vezzoli, M. Bonomi
The role of Obstructive Sleep Apnea and CPAP therapy in the functional hypogonadism of male patients with severe obesity
2025 A. Amodeo, B. Cangiano, N. Del Duca, A. Chilà, A. Musolino, I. Garavaglia, E. Delle Donne, A. Casiraghi, C. Manzini, V. Vezzoli, D. Sola, I. Gentile, A. Palo, G. Goggi, S. Federici, L. Persani, M. Scacchi, M. Bonomi
Impact of wfs1b downregulation on GnRH3 neurons development in the zebrafish model
2025 I. Gentile, F. Marelli, L. Persani, V. Vezzoli, M. Bonomi
Prevalence of hypercortisolism in hypertension and its link to carotid atherosclerosis markers
2025 A. Musolino, C. Parazzoli, E. Delle Donne, V. Favero, C. Aresta, G. Bilo, A. Croce, M. Pengo, G. Parati, L. Persani, A. Scillitani, I. Chiodini, V. Morelli